Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Autoimmune Diseases × Infliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 8 Melanoma 5 Inflammatory Bowel Diseases 5 Crohn Disease 5 Colitis, Ulcerative 5 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Colitis 3 Urogenital Neoplasms 2 Hematologic Neoplasms 2 Depressive Disorder, Major 2 Depression 2 Cachexia 2 Anorexia 2 Vasculitis 1 Takayasu Arteritis 1 Syndrome 1 Stroke 1 Stevens-Johnson Syndrome 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Rare Diseases 1 Psoriasis 1 Precancerous Conditions 1 Pemphigoid, Benign Mucous Membrane 1 Pancreatic Neoplasms 1 Lymphoma 1 Kidney Transplantation 1 Inflammation 1 Infections 1

Interventions

telitacicept 3 fludarabine 3 Prednisone 3 Data Collection 3 Cyclophosphamide 3 Specimen Handling 2 Nivolumab 2 Blood Specimen Collection 2 Antilymphocyte Serum 2 thymoglobulin 1 remdesivir 1 prednylidene 1 human papillomavirus vaccine, L1 type 16, 18 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 apremilast 1 Watchful Waiting 1 Vitamin D 1 Valsartan 1 Surveys and Questionnaires 1 Standard of Care 1 Pyridostigmine Bromide 1 Practice Guidelines as Topic 1 Population Groups 1 Plasma Exchange 1 Phlebotomy 1 Peripheral Blood Stem Cell Transplantation 1 Music Therapy 1 Methods 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown

Arthritis, Rheumatoid, Autoimmune Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡